Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Europe dares to reopen as 200 millionth vaccine dose delivered

Mon, 10th May 2021 13:41

By Michael Gore and Estelle Shirbon

MADRID/LONDON, May 10 (Reuters) - As its vaccination drive
reaches a third of adults and COVID-19 infections ease, Europe
is starting to reopen cities and beaches, raising hopes that
this summer's holiday season can be saved before it is too late.

Exhilarated Spaniards chanting "freedom" danced in the
streets as a COVID-19 curfew ended in most of the country at the
weekend, while Greece reopened public beaches - with deckchairs
safely spaced.

With 200 million vaccine doses delivered, the European Union
is on track to achieve its goal of inoculating 70% of its adult
population by summer, Commission President Ursula von der Leyen
tweeted on Sunday.

And, in Germany, a first weekend of summer sun lifted
spirits after Health Minister Jens Spahn declared the third wave
of the pandemic finally broken.

Yet, Spahn warned: "The mood is better than the reality."

The national seven-day incidence of COVID-19 cases remains
high at 119 per 100,000 people, he said. "That makes it all the
more important to keep up the speed of the vaccination
campaign."

Across the EU, the seven-day incidence of COVID-19 is 185,
according to Our World in Data. That is far higher than in
countries such as Israel with 6, Britain (31), or the United
States (123), all of which made quicker early progress in their
vaccination drives.

HEAD START

In Britain, early orders and approval of vaccines and a
decision to give first doses to as many people as possible have
driven down infections and fatalities far more quickly.

Prime Minister Boris Johnson was expected to set out the
next phase of lockdown easing in England, giving the green light
to "cautious hugging" and allowing pubs to serve customers pints
inside after months of strict measures.

"The data reflects what we already knew - we are not going
to let this virus beat us," Johnson said ahead of an official
announcement later on Monday.

Vaccine deliveries were slower initially in the EU under its
centralised procurement strategy.

Now, with shots from BioNTech/Pfizer and Moderna relatively
plentiful, vaccinations as a share of the population in Europe
are growing while countries that made early advances see
slowdowns as they encounter hesitancy among the unvaccinated.

Some 31.6% of adults in 30 European countries have received
a first dose and 12% a full two-shot regime, the European Centre
for Disease Prevention and Control's COVID-19 Vaccine Tracker https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab
showed.

France expects to give 20 million first injections by
mid-May, and hit 30 million by mid-June.

With infection rates falling and occupancy in hospital
intensive care units declining, France plans to start relaxing
its curfew and allow cafes, bars and restaurants to offer
outdoor service from May 19.

PICKING AND CHOOSING

Improving supply has given countries greater freedom to
adapt their strategies following reports of very rare, but
sometimes fatal, blood clotting in people who received shots
from AstraZeneca and Johnson & Johnson.

Germany has decided to make the two vaccines available to
anyone who wants them, as long as they have been advised by a
doctor - an offer aimed at younger adults who would have to wait
their turn otherwise.

Norway's vaccine commission made a similar call on Monday,
saying the AstraZeneca and J&J shots should be made available to
volunteers. Some Italian regions are also offering both shots to
people under 60.

With some governments shortening the gaps between doses, and
plans for an EU digital "green pass" scheme in June for
travellers to provide proof of vaccination or immunity, people
cooped up for months are finally daring to make holiday plans.

"We're pinning our hopes on tourism," said Nikos Venieris,
who manages a beach in Alimos, an Athens suburb.

Tourism accounts for about a fifth of Greece's economy and
jobs, and the country can ill afford another lost summer. Greece
is lifting restrictions on vaccinated foreigners from May 15.

(Writing by Douglas Busvine
Additional reporting by Jordi Rubio, Terje Solsvik, Gwladys
Fouche, Matthias Blamont, Emilio Parodi, John Miller, Alan
Charlish and Phoebe Fronista
Editing by Giles Elgood)

More News
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.